Screener
MiMedx Group MDXG EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from MiMedx Group’s reported figures.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
FAQ
- What is MiMedx Group's EBITDA?
- MiMedx Group (MDXG) reported EBITDA of -$18.18M in Q2 2026.
- How has MiMedx Group's EBITDA changed year-over-year?
- MiMedx Group's EBITDA decreased by 213.0% year-over-year, from $16.09M to -$18.18M.
- What is the long-term trend for MiMedx Group's EBITDA?
- Over 3 years (2022 to 2025), MiMedx Group's EBITDA has grown at a 53.0% compound annual growth rate (CAGR), from -$21.99M to $78.77M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about MiMedx Group's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude